Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
C4 Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 6,617 shares
@ $1.7, valued at
$11.2k
|
|
| 10/03/2023 |
4
| Dubin Glenn (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 6,470 shares
@ $1.7, valued at
$11k
|
|
| 10/03/2023 |
4
| GROGAN DONNA ROY (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 8,089 shares
@ $1.7, valued at
$13.8k
|
|
| 07/12/2023 |
4
| REYNO LEONARD (Chief Medical Officer) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 61,300 shares
@ $0
Granted 276,000 options to buy
@ $3.5, valued at
$966k
|
|
| 07/05/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 3,976 shares
@ $2.83, valued at
$11.3k
|
|
| 07/05/2023 |
4
| Dubin Glenn (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 3,887 shares
@ $2.83, valued at
$11k
|
|
| 07/05/2023 |
4
| GROGAN DONNA ROY (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 4,858 shares
@ $2.83, valued at
$13.7k
|
|
| 06/16/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 06/16/2023 |
4
| Bessen Laura (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 06/16/2023 |
4
| DOWNEY BRUCE (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 06/16/2023 |
4
| Dubin Glenn (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 06/16/2023 |
4
| GROGAN DONNA ROY (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 06/16/2023 |
4
| Koppikar Utpal (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 06/16/2023 |
4
| Salter Malcolm (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 04/04/2023 |
4
| Dubin Glenn (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 3,438 shares
@ $3.2, valued at
$11k
|
|
| 04/04/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 3,516 shares
@ $3.2, valued at
$11.3k
|
|
| 04/04/2023 |
4
| GROGAN DONNA ROY (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 4,298 shares
@ $3.2, valued at
$13.8k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Exercised 268 options to buy
@ $2.11, valued at
$565.5
Exercised 444 options to buy
@ $4.98, valued at
$2.2k
|
|
| 01/04/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 1,568 shares
@ $6.38, valued at
$10k
|
|
| 01/04/2023 |
4
| GROGAN DONNA ROY (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 1,763 shares
@ $6.38, valued at
$11.2k
|
|
| 01/04/2023 |
4
| Dubin Glenn (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 1,725 shares
@ $6.38, valued at
$11k
|
|
| 10/04/2022 |
4
| GROGAN DONNA ROY (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 819 shares
@ $8.69, valued at
$7.1k
|
|
| 10/04/2022 |
4
| Dubin Glenn (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 1,265 shares
@ $8.69, valued at
$11k
|
|
| 10/04/2022 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 1,150 shares
@ $8.69, valued at
$10k
Exercised 267 options to buy
@ $2.11, valued at
$563.4
Exercised 445 options to buy
@ $4.98, valued at
$2.2k
|
|
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2022 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Exercised 535 options to buy
@ $2.11, valued at
$1.1k
Exercised 889 options to buy
@ $4.98, valued at
$4.4k
|
|
|
|
|